Subject(s)

Fluvastatin/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Neoplasms/drug therapy , Apoptosis/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Epithelial-Mesenchymal Transition/drug effects , Fluvastatin/therapeutic use , Gene Expression Regulation, Neoplastic/drug effects , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Neoplasms/pathology

Subject(s)

Growth Inhibitors/therapeutic use , Kaempferols/therapeutic use , Urologic Neoplasms/drug therapy , Cell Proliferation/drug effects , Cell Proliferation/physiology , Growth Inhibitors/pharmacology , Humans , Kaempferols/pharmacology , Treatment Outcome , Urologic Neoplasms/pathology

Subject(s)

Alzheimer Disease/drug therapy , Clinical Medicine/methods , Minocycline/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Humans

Subject(s)

Prune Belly Syndrome/diagnosis , Prune Belly Syndrome/therapy , Female , Humans , Infant, Newborn , Male , Prune Belly Syndrome/etiology

Subject(s)

Alzheimer Disease/drug therapy , Antiparkinson Agents/therapeutic use , Brain/drug effects , Edaravone/therapeutic use , Neuroprotective Agents/therapeutic use , Parkinson Disease/drug therapy , Alzheimer Disease/diagnosis , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Animals , Brain/metabolism , Brain/pathology , Brain/physiopathology , Disease Models, Animal , Humans , Parkinson Disease/diagnosis , Parkinson Disease/metabolism , Parkinson Disease/physiopathology

Subject(s)

Flavanones , Flavonoids , Disease Progression , Humans , Liver Diseases

Subject(s)

Antineoplastic Agents/therapeutic use , Chloroquine/therapeutic use , Gastrointestinal Neoplasms/drug therapy , Antineoplastic Agents/pharmacology , Beclin-1/genetics , Beclin-1/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Chemokine CXCL12/genetics , Chemokine CXCL12/metabolism , Chloroquine/pharmacology , Humans , Matrix Metalloproteinase 7/metabolism , Receptors, CXCR4/antagonists & inhibitors , Receptors, CXCR4/metabolism , Signal Transduction/drug effects , Transcription Factor RelA/antagonists & inhibitors , Transcription Factor RelA/metabolism

Subject(s)

Antineoplastic Agents/pharmacology , Neoplasms/drug therapy , Rosuvastatin Calcium/pharmacology , Vascular Remodeling/drug effects , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cell Proliferation/drug effects , Humans , Neoplasms/pathology , Rosuvastatin Calcium/therapeutic use

Subject(s)

Acanthosis Nigricans/etiology , Acanthosis Nigricans/physiopathology , Ectodermal Dysplasia/complications , Hypohidrosis/complications , Acanthosis Nigricans/complications , Acanthosis Nigricans/diagnosis , Acanthosis Nigricans/drug therapy , Acitretin/therapeutic use , Child , Child, Preschool , Ectodermal Dysplasia/diagnosis , Ectodermal Dysplasia/drug therapy , Female , Humans , Hypohidrosis/diagnosis , Hypohidrosis/drug therapy , Male , Rare Diseases , Risk Assessment , Severity of Illness Index , Treatment Outcome

Subject(s)

Antineoplastic Agents , Benzofurans , Humans

Subject(s)

Hypertelorism , Surgery, Computer-Assisted , Humans , Imaging, Three-Dimensional

Subject(s)

Neoplasms/pathology , Triterpenes/pharmacology , Animals , Humans , Pentacyclic Triterpenes , Triterpenes/metabolism

Subject(s)

Stevens-Johnson Syndrome/diagnosis , Humans , Stevens-Johnson Syndrome/etiology

Subject(s)

Corneal Opacity/diagnosis , Corneal Opacity/genetics , Hyperlipoproteinemias/genetics , Hypoalphalipoproteinemias/diagnosis , Corneal Opacity/blood , Diagnosis, Differential , Humans , Hyperlipoproteinemias/blood , Hyperlipoproteinemias/diagnosis , Hypoalphalipoproteinemias/blood , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Lipoproteins, VLDL/blood , Mutation , Phosphatidylcholine-Sterol O-Acyltransferase/blood , Phosphatidylcholine-Sterol O-Acyltransferase/genetics , Triglycerides/blood

Subject(s)

Connexin 43/genetics , Connexins/genetics , Mutation , Skin Diseases/genetics , Humans

Subject(s)

Theophylline , Humans

Subject(s)

Acute Lung Injury/prevention & control , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Fluorobenzenes/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use , Animals , Male

Subject(s)

Intestinal Pseudo-Obstruction/diagnosis , Female , Humans , Male